Guidelines on diagnostics and treatment of acromegaly (draft)

Guidelines on diagnostics and treatment of acromegaly (draft)

We recommend acromegaly to be ruled in all patients with characteristic changes in appearance (A3). In all patients without characteristic changes in appearance, we recommend to rule out acromegaly, if several clinical signs suspicious for acromegaly are present (B3). We recommend acromegaly to be r...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: E. G. Przhiyalkovskaya, N. G. Mokrysheva, E. A. Troshina, G. A. Melnichenko, I. I. Dedov, M. B. Antsiferov, L. I. Astafieva, T. P. Bardymova, Zh. E. Belaya, G. R. Vagapova, S. Yu. Vorotnikova, A. Yu. Grigoriev, E. N. Grineva, L. K. Dzeranova, I. A. Ilovaiskaya, P. L. Kalinin, A. M. Lapshina, A. S. Lutsenko, E. O. Mamedova, E. I. Marova, M. A. Perepelova, E. A. Pigarova, V. S. Pronin, L. Ya. Rozhinskaya, Yu. Yu. Trunin, A. S. Shutova
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Endocrinology Research Centre 2024-08-01
Seri Bilgileri:Ожирение и метаболизм
Konular:
acromegaly
pituitary adenoma
growth hormone
insulin-like growth factor-1
octreotide
lanreotide
pegvisomant
Online Erişim:https://www.omet-endojournals.ru/jour/article/view/13153

Internet

https://www.omet-endojournals.ru/jour/article/view/13153

Benzer Materyaller